LEXINGTON, Mass.--(BUSINESS WIRE)--April 27, 2006--NitroMed Inc. (NASDAQ: NTMD - News) today announced that it will present at Morgan Stanley's Global Healthcare Unplugged conference, being held May 3 - 5 at The Mandarin Oriental Miami. Jerry N. Karabelas, Ph.D., NitroMed's Chairman and interim Chief Executive Officer, will discuss the Company's progress and plans, particularly with respect to the commercial launch of BiDil® (isosorbide dinitrate/hydralazine hydrochloride), in this open forum presentation to be held on Wednesday, May 3, at 10:30 am (ET).
